Fabior Topical and Linagliptin and Metformin Extended-Release Tablets
Determining the interaction of Fabior Topical and Linagliptin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tazarotene topical
Brand name: Avage, Fabior, Tazorac
Synonyms: Fabior, Fabior Foam
Generic Name: linagliptin / metformin
Brand name: Jentadueto, Jentadueto XR
Synonyms: Linagliptin and metformin, Linagliptin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fabior Topical-Linagliptin and Metformin Tablets
- Fabior Topical-Lincocin
- Fabior Topical-Lincomycin
- Fabior Topical-Lincomycin Hydrochloride
- Fabior Topical-Lincomycin Injection
- Fabior Topical-Lincomycin Oral, Injection
- Linagliptin and Metformin Extended-Release Tablets-Fabrazyme
- Linagliptin and Metformin Extended-Release Tablets-Factive
- Linagliptin and Metformin Extended-Release Tablets-Factor IX (Human)
- Linagliptin and Metformin Extended-Release Tablets-Factor IX (Human), Factor IX Complex (Human)
- Linagliptin and Metformin Extended-Release Tablets-Factor IX (Recombinant [Albumin Fusion Protein])
- Linagliptin and Metformin Extended-Release Tablets-Factor IX (Recombinant [Fc Fusion Protein])